Latest News of QURE
Qure.ai secures $65m in Series B financing to expand into US and other markets
Qure.ai, an Indian healthcare tech company, raised $65m in a Series D round to expand into the US and other regions, invest in AI models, and acquire medical tech companies. The company aims to improv...
UniQure's Fabry Disease Treatment Gets Orphan Drug Designation from FDA
UniQure received FDA orphan drug designation for AMT-191, a potential gene therapy for Fabry disease. This rare genetic disorder affects multiple body systems due to a gene deficiency. The company has...
uniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know
uniQure N.V. reported bullish quarterly results with revenues beating estimates by 65%. Analysts expect a 66% revenue increase in 2024, despite a forecasted loss reduction. However, forecasts show a w...
-
uniQure N.V. (NASDAQ:QURE) is a favorite amongst institutional investors who own 52%
By Yahoo! Finance | 4 months agoInstitutional investors hold a majority stake in uniQure, impacting stock price. Hedge funds and CEO also own shares. Analysts recommend considering ownership structure alongside other factors for inv...